Methadone in Pediatric Anesthesia
Information source: Washington University School of Medicine
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Anesthesia
Intervention: Methadone (Drug)
Phase: N/A
Status: Recruiting
Sponsored by: Washington University School of Medicine Official(s) and/or principal investigator(s):
Evan Kharasch, MD, PhD, Principal Investigator, Affiliation: Washington University School of Medicine
Overall contact:
Jane Blood, RN, Phone: 314-747-5531, Email: bloodj@wustl.edu
Summary
This study will determine the pharmacokinetics of intravenous (IV) methadone in children
undergoing surgery.
Clinical Details
Official title: Methadone in Pediatric Anesthesia
Study design: Treatment, Open Label, Active Control, Single Group Assignment, Efficacy Study
Primary outcome: Determine PKs of IV methadone in children undergoing surgery
Eligibility
Minimum age: 5 Years.
Maximum age: 18 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Age 5-18
- Undergoing General anesthesia and surgery with anticipated postoperative inpatient
stay of greater than or equal to 3 days
- Signed, written, informed consent from legal guardians and assent from patient
Exclusion Criteria:
- History of or known liver or kidney disease
Locations and Contacts
Jane Blood, RN, Phone: 314-747-5531, Email: bloodj@wustl.edu
Washington University School of Medicine, St. Louis, Missouri 63110, United States; Recruiting
Additional Information
Starting date: May 2009
Ending date: May 2010
Last updated: September 11, 2009
|
